Ibrexafungerp or Caspofungin in Combination with Azoles against Clinical Isolates of Aspergillus, Including Those Resistant to Azoles

Presenter
  • V. Jagadeesan
Session
Virtual 335 - AAR08 New Antimicrobial Agents (in vitro and in vivo Studies Prior to the Start of Clinical Therapeutic Studies/Pre-phase 2) - In vitro and In vivo study of new antimicrobials

Previous ePoster
Discovery of Mobile Triclosan Tolerance Genes in Pseudomonas Using High-throughput Conserved Gene Synteny Analysis

Next ePoster
Genetic Diversity and Epidemiology of Accessory Gene Regulator Loci in the Clinical Isolates of Clostridioides Difficile
Comparison of Classical Molecular Methods and Whole Genome Sequencing for Identification and Typing of Acinetobacter Baumannii Strains from Two Major Hospitals in Kuwait
The Roll Oo Th17 and Treg Cells in Progression and Regression of Salmonella typhi Infection
Bio-inspired Synthesis & Bio-catalytic Activity of Zinc Oxide Nanoparticles Using Seed Extract of Citrullus Lanatus against Antibiotics Resistant Pathogenic Bacteria
Optimization of Alkaline Protease Production in Submerged Fermentation by Bacillus Cereus Isolated from an Abattoir Wastewater in Ile-ife, Nigeria
Assessment of Environmental Bacteria for Resistance to Cetylpyridinium Chloride, Modes of Potential Resistance Transmission, and Clinical Applications
Purification and Characterization of Antifungal Bacteriocin Produced by Bacillus velezensis From Raw Honey
Preparation of Cohort Specific Fecal Reference Material for Use in Microbiome Studies
Differential Survival of Corynebacteria to Cold Shock Mayexplain their Abundance in the Gut Microbiome of Hummingbirds
TLR2 Agonist as Adjuvant in Vaccination Strategy against Experimental Cryptococcosis